TARA FY 2013 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$212M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$27,000

Operating Income

-$7M

Net Income

-$8M

EPS (Diluted)

$-37.43

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$6M

Total Liabilities

$10M

Stockholders' Equity

-$4M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$27,000	-$57,000	+52.6%
Operating Income	-$7M	-$8M	+10.9%
Net Income	-$8M	-$8M	+0.7%